Akari Therapeutics Plc (AKTX)
0.41
+0.03
(+7.87%)
USD |
NASDAQ |
Dec 11, 16:00
0.4092
0.00 (0.00%)
After-Hours: 07:37
Akari Therapeutics Cash from Investing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| DBV Technologies SA | -0.2404M |
| Cellectis SA | -3.266M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.0656M |
| Autolus Therapeutics Plc | 35.49M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.102M |
| Cash from Financing (Quarterly) | 1.876M |
| Free Cash Flow | -9.678M |
| Free Cash Flow Per Share (Quarterly) | -0.0643 |
| Free Cash Flow to Equity (Quarterly) | -2.672M |
| Free Cash Flow to Firm (Quarterly) | -1.999M |
| Free Cash Flow Yield | -77.45% |